First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis

201420 citationsJournal Articlediamond Open Access

Authors

Natavan Alikhanova

İrada Akhundova

Mehriban Seyfaddinova

Elcan Mammadbayov

V. Mirtskulava · Battelle

Sabine Rüsch–Gerdes · Research Center Borstel - Leibniz Lung Center

R. Bayramov · Azerbaijan Medical University

J. Suleymanova

Kristin Kremer · World Health Organization Regional Office for Europe

Abstract

Azerbaijan remains a high MDR-TB burden country. There is a need to implement countrywide control and innovative measures to accelerate early diagnosis of drug resistance in individual patients, improve treatment adherence and strengthen routine surveillance of drug resistance.

Topics & Keywords

Tuberculosis Research and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Public Health Action

Volume 4, Issue Supplement 2, pp. S17-S23

DOI: 10.5588/pha.14.0049

Field-Weighted Citation Impact: 1.08